A Double-Blinded Randomised Placebo-Controlled Phase II Trial to Evaluate High Dose Rifampicin for Tuberculous Meningitis: A Dose Finding Study

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01014-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

High Dose Oral Rifampicin to Improve Survival From Adult Tuberculous Meningitis: A Randomised Placebo-Controlled Double-Blinded Phase III Trial (The HARVEST Study)

Wellcome Open Research
BiochemistryMedicineGeneticsMolecular Biology
2019English

Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial

The Lancet Neurology
Neurology
2013English

Orally Active Prostacyclin Analogue Beraprost Sodium in Patients With Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Dose Finding Trial

BMC Nephrology
Nephrology
2015English

Corrigendum: Perioperative Bromelain Therapy After Wisdom Teeth Extraction - A Randomized, Placebo-Controlled, Double-Blinded, Three-Armed, Cross-Over Dose-Finding Study

Phytotherapy Research
Pharmacology
2017English

A Phase II Randomized Controlled Trial Adding Oral Flucytosine to High-Dose Fluconazole, With Short-Course Amphotericin B, for Cryptococcal Meningitis

AIDS
Infectious DiseasesAllergyImmunology
2012English

High-Dose Vitamin D3 During Intensive-Phase Antimicrobial Treatment of Pulmonary Tuberculosis: A Double-Blind Randomised Controlled Trial

The Lancet
Medicine
2011English

A Pragmatic, Phase III, Multisite, Double-Blind, Placebo-Controlled, Parallel-Arm, Dose Increment Randomised Trial of Regular, Low-Dose Extended-Release Morphine for Chronic Breathlessness: Breathlessness, Exertion and Morphine Sulfate (BEAMS) Study Protocol

BMJ Open
Medicine
2017English

Bumetanide in Hypokalaemic Periodic Paralysis: A Randomised, Double-Blind, Placebo Controlled Phase II Clinical Trial With a Crossover Design

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2016English

Medium-Dose Riboflavin as a Prophylactic Agent in Children With Migraine: A Preliminary Placebo-Controlled, Randomised, Double-Blind, Cross-Over Trial

Cephalalgia
MedicineNeurology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy